abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for abrdn Life Sciences Investors Shares of Beneficial Interest, updated every trading day.
Finance · Investment Managers
Price
$18.28
+1.56% today
Market cap
$462M
Overall quality
—
Kronos AI 30-day
+0.4%
5 of 8 simulated paths end higher
abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) is a Finance company in Investment Managers, worth $462M. It trades at $18.28, up 1.56% today. Kronos AI's 30-day forecast is +0.4% (5 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $18.07 (+0.4%) |
| Likely range | −1.3% … +10.7% |
| As of | 2026-10-27 |
5 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Does not pass |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Investment Managers
For information only, not investment advice. Prices updated: 2026-10-29.